天目药业聘任党国峻担任公司财务总监

Group 1 - Tianmu Pharmaceutical announced the resignation of Wang Yihui from the positions of director, member of the strategic committee, and financial director due to work relocation [1] - The company appointed Han Tongmin as the new deputy general manager and Dang Guojun as the new financial director, effective from the date of board approval until the end of the current board term [1] - Huang Junde was elected as a member of the compensation and assessment committee, also until the end of the current board term [1] Group 2 - For the fiscal year 2024, Tianmu Pharmaceutical's revenue composition is as follows: health products 31.37%, pharmaceutical circulation products 21.97%, service category 19.74%, raw materials 12.64%, and traditional Chinese medicine 11.84% [1] - As of the report date, Tianmu Pharmaceutical has a market capitalization of 2.3 billion yuan [1]